Early studies suggest an initial vaccine series provides little protection against infection from omicron—but is still effective against severe disease—and a booster shot is necessary for higher levels of immunity.
Early lab data released Wednesday suggests a booster shot of the Pfizer-BioNTech vaccine is necessary to ensure protection against omicron, rather than just two doses.